Mashelkar suggestion to grant patent for incremental modifications to benefit only MNCs (PharmaBiz)
Mashelkar suggestion to grant patent for incremental modifications to benefit only MNCs (PharmaBiz)
The recommendation of Dr Mashelkar panel to encourage incremental innovations by the patent regime assumed great relevance to India and it would go a long way to make drugs available at affordable prices, according to Ranjit Shahani, president of Organization of Pharmaceutical Producers of India.